St. Augustine, FL 07/23/2018- Flagler Hospital St. Augustine in St. Augustine is utilizing new and innovative technology, using the FDA-Cleared Radial-to-Peripheral (R2P) sheath from Terumo Medical Corporation, the Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device (OAD) from Cardiovascular Systems, Inc. (CSI®), and the Ultraverse RX .014/200cm balloon from Bard Medical to treat patients with peripheral artery disease (PAD).
PAD affects as many as 18 million Americans and is a circulatory condition in which narrowed and hardened blood vessels reduce blood flow to the limbs and, if left untreated, could lead to limb amputation. When intervention is needed, PAD can be treated by atherectomy – a minimally invasive procedure to open blocked arteries by using a device on the end of a catheter to remove built up plaque. Then, a balloon angioplasty or stent procedures is completed to restore blood flow. Treatment of PAD previously required a surgical operation with the risk of pain, long recovery times, and significant cost. In recent years, many of these procedures have been performed using minimally invasive vascular surgery using a femoral artery (groin) access. Though the recovery time and procedural risks are reduced, pain and bleeding have remained important challenges. Today, many of these challenges are overcome by a new and even safe approach to treating peripheral artery disease using the radial artery (wrist). Due to engineering breakthroughs and novel equipment, occluded leg arteries can be reopened from the radial artery. Patients are able go home following this approach on the same day, usually only a few hours later.
This technology is a huge win for patients as treatment of PAD from the wrist, instead of the groin, reduces invasiveness, and often results in a better patient experience and faster recovery,” said Dr. Imraan Ansaarie “This new technology allows us to use the wrist as an access point to help minimize bleeding and avoid groin access. Most importantly, our patients will experience fewer complications, faster recovery, and shorter return to their daily lives. Patients can walk within thirty minutes of the procedure and recover in a soft reclining chair.”
Dr. Imraan Ansaarie, MD with Ansaarie Cardiac and Endovascular Center of Excellence began using the Extended Length Peripheral OAD technology on July 23, 2018.
Dr. Ansaarie Noted- “When performing a radial-to-peripheral procedure, the radial artery is accessed with direct visualization of the artery with ultrasound. Complex peripheral arteries can re-opened by using atherectomy and balloon angioplasty in the same manner as the former procedure. This approach is a dream come true for patients in the St. Augustine area. This procedure is rapidly becoming a standard approach for patients at Flagler Hospital. With new devices which are designed for the radial approach, we anticipate that this will become the first line approach for endovascular procedures in the future. With this approach, patient satisfaction scores have exceeded the national average, and in our experience, there have been access site complications. At Flagler Hospital in St. Augustine, FL we have performed more than 30 radial-to-peripheral interventions with a varying degree of complexities and are consistently producing successful results”.
About Peripheral Artery Disease (PAD) As many as 18 million Americans, most over age 65, suffer from PAD, which is caused by the accumulation of plaque in peripheral arteries reducing blood flow. Symptoms include leg pain when walking or at rest. Left untreated, PAD can lead to severe pain, immobility, non-healing wounds and eventually limb amputation. With risk factors such as diabetes and obesity on the rise, the prevalence of PAD is growing at double-digit rates. Literature shows that Balloon angioplasty and stents can have significant shortcomings in treating hard, calcified lesions. Stents are prone to fractures and high recurrence rates, and treatment of hard, calcified lesions often leads to vessel damage and suboptimal results. Millions of patients with PAD may benefit from treatment with orbital atherectomy utilizing the Diamondback 360®, which are minimally invasive catheter systems developed and manufactured by CSI. These systems use a diamond-coated crown, attached to an orbiting shaft, which sands away plaque while preserving healthy vessel tissue — a critical factor in preventing reoccurrences.